Aurobindo Pharma Q3 2024 Results

News: Aurobindo Pharma, a big name in Indian medicine, is getting ready to reveal how well it did in the third quarter of 2024. Let’s explore the important stuff about Aurobindo Pharma’s Q3 results, like how much money it made, how its shares did, and what’s coming up next.

Big Jump in Profit

• Profit Increase: Aurobindo Pharma’s total profit for Q3 FY24 shot up by a whopping 90.6% from last year. This time, the company made Rs 936.2 crore, which is a lot more than the Rs 491.2 crore it made in the same period last year¹.
• This huge growth shows that Aurobindo Pharma is doing really well and making smart moves.

Subscribe to Sarkari Result to stay informed. Get the latest celebrity news and detailed movie reviews in real-time. Keep up with the constantly changing world of entertainment with Sarkari Exam.

Revenue and Earnings

• Money from Operations: In Q3 FY24, Aurobindo Pharma made Rs 7,351.7 crore from its operations, which is 14.7% more than what it made in the same period last year¹.
• EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization): The company’s EBITDA went up to Rs 1,601. crore from Rs 954.4 crore last year. And the EBITDA margin, which is how much profit it keeps compared to its earnings, got a lot better, going from 14.9% to 21.8%¹.

Share Price and How People Feel

• People are really interested in how Aurobindo Pharma’s stock did in Q3 FY24. The company’s share price changes can tell us a lot about how people feel about it and the market.
• Experts think the company will do well, especially because it’s selling a lot in America and Europe, and it’s making more money⁴.

What’s Next?

• Investors and others are excited to know what’s next for Aurobindo Pharma. The announcement on February 10, 2024, will give us a good idea about its future plans².

Aurobindo Pharma’s Q3 results show it’s growing strong. Let’s keep an eye out for more updates as it keeps moving forward in the healthcare world.

Frequently Asked Questions

Q: What are the main things the board meeting will talk about?

A: The board meeting will mainly discuss how well the company is doing financially, where to invest money, how to use funds wisely, how to manage risks, the rules for running the company, and important plans for the future.

Q: What will we learn from the unaudited financial statements?

A: The unaudited financial statements will tell us all about how the company’s money looks for the last three months and the nine months up to December 31, 2023.

Q: Where does Aurobindo Pharma have its main office?

A: Aurobindo Pharma’s main office is in HITEC City, Hyderabad, India.